Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled double-blind crossover study

Urology

Volumn 49, Issue 3, 1997, Pages 441-444

  Kunelius, Pekka ^a   Häkkinen, Jukka ^a   Lukkarinen, Olavi ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

YOHIMBINE;

ADULT; ARTICLE; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CAVERNOSUM; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMPOTENCE; MALE; MALE INFERTILITY; ORAL DRUG ADMINISTRATION; PENIS ERECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX THERAPY; SYNAPTIC TRANSMISSION;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOHIMBINE;

EID: 0343581280     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00505-5     Document Type: Article

References (21)

1. Atala A, and Amin M: Current concepts in the treatment of genitourinary tract disorders in the older individual. Drugs Aging 1: 176-193, 1991.
2. Deamer RL, and Thompson JF: The role of medications in geriatric sexual function. Clin Geriatr Med 7: 95-111, 1991.
3. Virag R, Shoukry K, Floresco J, Nollet F, and Greco E: Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. J Urol 145: 287-293, 1991.
4. von Heyden B, Donatucci CF, Kaula N, and Lue TF: Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. J Urol 149: 1288-1290, 1993.
5. Cookson MS, Phillips DL, Huff ME, and Fitch WP 3rd: Analysis of microsurgical penile revascularization results by etiology of impotence. J Urol 149: 1308-1312, 1993.
6. Nickas ME, Kessle R, and Kabalin JN: Long-term experience with controlled expansion cylinders in the AMS 700CX inflatable penile prosthesis and comparison with earlier versions of the Scott inflatable penile prosthesis. Urology 44: 400-403, 1994.
7. Montorsi F, Guazzoni G, Bergamaschi F, Ferini-Strambi L, Barbieri L, and Rigatti P: Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction. J Urol 149: 1291-1295, 1993.
8. Fouda A, Hassouna M, Beddoe E, Kalogeropoulos D, Binik YM, and Elhilali MM: Priapism: an avoidable complication of pharmacologically induced erection. J Urol 142: 995-997, 1989.
9. Fuchs ME, and Brawer MK: Papaverine-induced fibrosis of the corpus cavernosum. J Urol 141: 125, 1989.
10. Hashmat AI, Abrahams J, Fani K, and Nostrand I: A lethal complication of papaverine-induced priapism. J Urol 145: 146-147, 1991.
11. Farjam A, and Greven J: Effects of the alpha 2-adrenoceptor antagonists yohimbine and idazoxan on kidney function in intact and diabetes insipidus rats. Urol Int 44: 255-259, 1989.
12. Susset JG, Tessier CD, Wincze J, Bansal S, Malhotra C, and Schwacha MG: Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol 141: 1360-1363, 1989.
13. Owen JA, Nakatsu SL, Concha M, Surridge DH, Fenemore J, and Morales A: Sub-nanogram analysis of yohimbine and related compounds by high-performance liquid chromatography. J Chromatogr 342: 333-340, 1985.
14. Murburg MM, Villacres EC, Ko GN, and Veith RC: Effects of yohimbine on human sympathetic nervous system function. J Clin Endocrinol Metab 73: 861-865, 1991.
15. Kirkeby HJ, Forman A, Sörensen S, and Andersson KE: Alpha-adrenoceptor function in isolated penile circumflex veins from potent and impotent men. J Urol 142: 1369-1371, 1989.
16. Nessel MA: Yohimbine and pentoxifylline in the treatment of erectile dysfunction. Am J Psychiatry 151: 453, 1994.
17. Montorsi F, Strambi LF, Guazzoni G, Galli L, Barbieri L, Rigatti P, Pizzini G, and Miani A: Effect of yohimbinetrazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. Urology 44: 732-736, 1994.
18. Hollander E, and McCarley A: Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 53: 207-209, 1992.
19. Reid K, Surridge DH, Morales A, Condra M, Harris C, Owen J, and Fenemore J: Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet 2: 421-423, 1987.
20. Sandler B, and Aronson P: Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urology 41: 343-345, 1993.
21. Landis E, and Shore E: Yohimbine-induced broncho-spasm. Chest 96: 1424, 1989.